© Globe Newswire
17.11.2025
ASND
LISTED
NASDAQ
Results of Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics
News Preview
COPENHAGEN, Denmark, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that pivotal Week 52 results from its randomized double-blind, placebo-controlled ApproaCH Trial of investigational once-weekly TransCon® CNP (navepegritide) in children with achondroplasia have been published in JAMA Pediatrics, a journal of...
Themefolio
Profiler
Peergroup
© BusinessWire
17.11.2025
INSP
LISTED
NYSE
Deadline Approaching: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).
IF YOU ARE...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.11.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Announces Positive Recommendation from Independent Data Monitoring Committee (IDMC) to Continue Pivotal Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer
News Preview
OSE Immunotherapeutics annonce que le Comité indépendant d’experts scientifiques (IDMC) recommande la poursuite d’ARTEMIA, l’essai pivot de Phase 3 de Tedo...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
17.11.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
News Preview
CONSHOHOCKEN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences:...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
17.11.2025
CTEC
LISTED
LSE
Convatec Selects LTIMindtree for Strategic, AI-Powered SAP S/4HANA Transformation
News Preview
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced its selection as a strategic partner by Convatec, a leading global medical products and technologies company, for the implementation of SAP’s Digital Core – S/4HANA. As part of this engagement, LTIMindtree will support Convatec to impl...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.11.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company Umecrine Cognition publishes data on the benefits of early treatment with golexanolone in Parkinson’s disease
News Preview
STOCKHOLM – November 17, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has published data in the scientific journal Neuropharmacology, showing sustained benefits of early treatment with golexanolone in a Parkinson's disease model. The data show that golexanolone may delay the...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.11.2025
FYB
LISTED
XETR
Biosimilar-Kandidat für Dupixent® (Dupilumab) als weiterer Wachstumstreiber im Formycon-Portfolio
News Preview
Pressemitteilung // 17. November 2025
Meilenstein bei FYB208 erreicht: Biosimilar-Kandidat für Dupixent® (Dupilumab) als weiterer Wachstumstreiber im Formycon-Portfolio
Wichtiger präklinischer Meilenstein Technical Proof of Similarity (TPoS) zeigt hohe analytische Vergleichbarkeit von FYB208 mit Referenzarzneimittel
Überzeugende in-vitro Daten......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.11.2025
FYB
LISTED
XETR
Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio
News Preview
Press Release // November 17, 2025
Milestone achieved with FYB208: Biosimilar candidate for Dupixent® (dupilumab) as another growth driver in Formycon's portfolio
Important preclinical milestone Technical Proof of Similarity (TPoS) demonstrates high analytical comparability of FYB208 to reference drug
Strong in vitro data support cost-effe......
Themefolio
Profiler
Peergroup
© BusinessWire
17.11.2025
MRSN
LISTED
NASDAQ
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Mersana Therapeutics, Inc. (NasdaqGS: MRSN) to Day One Biopharmaceuticals, Inc. Under the terms of the proposed transaction, shareholders of Mersana will receive $25.00 per share in cash plus...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
POAI
LISTED
NASDAQ
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy
News Preview
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy...
Themefolio
Profiler
Peergroup
© BusinessWire
14.11.2025
INSP
LISTED
NYSE
Law Offices of Frank R. Cruz Encourages Inspire Medical Systems, Inc. (INSP) Shareholders to Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead pla...
Themefolio
Profiler
Peergroup
© BusinessWire
14.11.2025
INSP
LISTED
NYSE
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Inspire Medical Systems, Inc. (INSP) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
14.11.2025
FAGR
LISTED
EURONEXT
Fagron completes share buy-back program
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 14 November 2025 – 6PM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
14.11.2025
TEM
LISTED
NASDAQ
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new research study sponsored by Tempus and being run in collaboration with the Institute for Follicular Lymphoma Innovation (IFLI), a global, nonprofit, private foundation dedicated to accelerating the development of inno...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
ORNBV
LISTED
HEL
Orion receives award for international growth from the President of the Republic of Finland
News Preview
ORION CORPORATION PRESS RELEASE 14 NOVEMBER 2025 at 13.30 EET Orion receives award for international growth from the President of the Republic of Finland...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
TFX
LISTED
NYSE
Teleflex to Present at the Jefferies Global Healthcare Conference in London
News Preview
WAYNE, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 10:00 a.m. (GMT)....
Themefolio
Profiler
Peergroup
© Newsfile
14.11.2025
COPN
LISTED
SIX
Winlevi(R) Receives Regulatory Approval in Brazil - Expanding Global Access to a Breakthrough Acne Treatment
News Preview
Dublin, Ireland--(Newsfile Corp. - November 14, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and dermatology innovations, today announced that the Brazilian Health Regulatory Agency (ANVISA) has approved Winlevi® (clascoterone) cream 1% for the treatment of acne vulgaris in patients aged tw...
Themefolio
Profiler
Peergroup
© EQS Newswire
14.11.2025
SOON
LISTED
SIX
Strong sales and earnings growth in local currencies, outperforming the market
News Preview
Group Media & Investor ReleaseAd hoc announcement pursuant to Art. 53 LR
Staefa (Switzerland), November 14, 2025 – Sonova Holding AG (SWX: SOON), a leading provider of innovative hearing solutions, today announces results for the first half of its 2025/26 financial year.
Group sales reached CHF 1,815.4 million, up 4.9% in local currencies. Th......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.11.2025
SOON
LISTED
SIX
Starkes Umsatz- und Gewinnwachstum in Lokalwährungen, deutlich über dem Markt
News Preview
Group Media & Investor ReleaseAd hoc-Mitteilung gemäss Art. 53 KR
Stäfa (Schweiz), 14. November 2025 – Die Sonova Holding AG (SWX: SOON), ein führender Anbieter innovativer Hörlösungen, gibt heute das Ergebnis für das erste Geschäftshalbjahr 2025/26 bekannt.
Der Gruppenumsatz erreichte CHF 1’815,4 Mio., was einem Anstieg von 4,9% in Lokalwähru......
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
KDEV
LISTED
STO
Interim Report - January-September 2025
News Preview
STOCKHOLM – 14 November 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-September 2025. The full report is available on the Company's website....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
BAVA
LISTED
CPH
Bavarian Nordic Announces Interim Results for the First Nine Months of 2025
News Preview
COPENHAGEN, Denmark, November 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2025 and business progress for the third quarter of 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
14.11.2025
BIOA B
LISTED
STO
Leqembi® approved for IV maintenance treatment in the United Kingdom
News Preview
STOCKHOLM, Nov. 13, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi (lecanemab) has been approved for once every four weeks intravenous (IV) maintenance dosing for the treatment of early Alzheimer's disease by the Medicines and Healthcare products R...
Themefolio
Profiler
Peergroup
© PR Newswire
14.11.2025
BIOA B
LISTED
STO
Leqembi® approved for IV maintenance treatment in the United Kingdom
News Preview
STOCKHOLM, Nov. 13, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi (lecanemab) has been approved for once every four weeks intravenous (IV) maintenance dosing for the treatment of early Alzheimer's disease by the Medicines and Healthcare products R...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
INSP
LISTED
NYSE
Law Offices of Howard G. Smith Encourages Inspire Medical Systems, Inc. (INSP) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintif...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
BAVA
LISTED
CPH
Bavarian Nordic Announces Changes to the Board of Directors
News Preview
COPENHAGEN, Denmark, November 13, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Chair of the Board, Luc Debruyne has decided to step down from the board with immediate effect....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
LEGN
LISTED
NASDAQ
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
News Preview
31,000-square-foot site expands Legend’s U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
News Preview
Inspire Medical Systems, Inc. (NYSE: INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical “next generation” sleep apnea device, the Inspire V. The litigation zeroes in on the disparity between the company's confident assurances and the subsequen...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
MRSN
LISTED
NASDAQ
MRSN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Mersana Therapeutics, Inc. is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Mersana Therapeutics, Inc. (NASDAQ: MRSN) to Day One Biopharmaceuticals, Inc. is fair to Mersana shareholders. Under the terms of the proposed transaction, Mersana shareholders will receive $25.00 per share in cash plus one non-tradable contingent value right (CVR)...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
TRAW
LISTED
NASDAQ
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
News Preview
Progressing Phase 2 studies for ratutrelvir, a ritonavir-free, protease inhibitor regimen in development for Acute and Long COVID with expected top line data by year end...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
TIL
LISTED
NASDAQ
Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
Instil Bio Reports Third Quarter 2025 Financial Results and
Provides Corporate Update...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
INSP
LISTED
NYSE
INSP INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned City of...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
SECT_B
LISTED
STO
Large health system in southeast US adopts Sectra's cloud service across 11 sites to ensure reliability in their delivery of excellent patient care
News Preview
LINKÖPING, Sweden, Nov. 13, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will deliver its enterprise imaging solution as a fully managed cloud service, Sectra One Cloud, to a multisite healthcare system in the US. The service, operated on the latest cloud te...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
BIOA B
LISTED
STO
Interim Report for the period July - September 2025: BioArctic
News Preview
STOCKHOLM, Nov. 13, 2025 /PRNewswire/ --
Broadening our portfolio with new projects and partnerships
Events during the third quarter 2025
New data on lecanemab were presented...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
BIOA B
LISTED
STO
Interim Report for the period July - September 2025: BioArctic
News Preview
STOCKHOLM, Nov. 13, 2025 /PRNewswire/ --
Broadening our portfolio with new projects and partnerships
Events during the third quarter 2025
New data on lecanemab were presented...
Themefolio
Profiler
Peergroup
© ActuNews
13.11.2025
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma announces the strong success of its approximately EUR 8 million capital increase to support its continued development and strengthen its financial structure
News Preview
Capital increase of €7.8 million through the issuance of 4,356,804 new shares at a unit price of €1.80
The transaction received strong support from existing shareholders, whose demand on irreducible and reducible basis, under the preferential subscription rights amounted to 1,742,660 shares
Lyon, France – November 13,...
Themefolio
Profiler
Peergroup
© ActuNews
13.11.2025
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma annonce le vif succès de son augmentation de capital d'environ 8M EUR pour poursuivre son développement et renforcer sa structure financière
News Preview
Augmentation de capital de 7,8M€ par émission de 4 356 804 actions nouvelles au prix unitaire de 1,80 €
L'opération a notamment suscité un fort engagement des actionnaires existants, dont la demande à titre irréductible et réductible, dans le cadre du maintien du DPS, est de 1&nbs...
Themefolio
Profiler
Peergroup
© EQS Newswire
13.11.2025
EUZ
LISTED
XETR
Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment
News Preview
3rd quarter of 2025:
Sales of €75.3 million (previous year: €70.1 million)
EBIT before special items of €15.4 million (previous year: €14.2 million)
Net income of €8.5 million (previous year: €5.3 million)
First 9 months of 2025:
Sales of €224.1 million (previous year: €215.5 million)
EBIT before special items of €50.8 million (previous year: ......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.11.2025
EUZ
LISTED
XETR
Eckert & Ziegler mit erneutem Ergebniswachstum und zweistelligem Umsatzwachstum im Segment Medical
News Preview
3. Quartal 2025:
Umsatz: 75,3 Mio. € (VJ: 70,1 Mio. €)
EBIT vor Sondereinflüssen: 15,4 Mio. € (VJ: 14,2 Mio. €)
Nettogewinn: 8,5 Mio. € (VJ: 5,3 Mio. €)
9-Monatszeitraum 2025:
Umsatz: 224,1 Mio. € (VJ: 215,5 Mio. €)
EBIT vor Sondereinflüssen: 50,8 Mio. € (VJ: 46,7 Mio. €)
Nettogewinn: 29,9 Mio. € (VJ: 23,4 Mio. €)
Jahresprognose 2025:
Umsatz......
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
AGFB
LISTED
EURONEXT
The Agfa-Gevaert Group in Q3 2025: continued decline in medical film, strong growth cloud and SaaS in HealthCare IT, soft markets in Digital Print & Chemicals
News Preview
Regulated information November 13, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q3 2025: continued decline in medical film, strong growth cloud and SaaS in HealthCare IT, soft markets in Digital Print & Chemicals...
Themefolio
Profiler
Peergroup
© EQS Newswire
13.11.2025
FYB
LISTED
XETR
Formycon veröffentlicht Neunmonatsergebnis und bestätigt Prognose – Pipeline-Fortschritte und starke Partnerschaften prägen Geschäftsjahr 2025
News Preview
Pressemitteilung // 13. November 2025
Formycon veröffentlicht Neunmonatsergebnis und bestätigt Prognose – Pipeline-Fortschritte und starke Partnerschaften prägen Geschäftsjahr 2025
Prognose für 2025 bestätigt – Umsatz- und Ergebnisentwicklung im Rahmen der Erwartungen
FYB202 (Stelara®1-Biosimilar): Markterschließung in den USA und Europa schrei......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.11.2025
FYB
LISTED
XETR
Formycon publishes nine-month results and confirms guidance – Pipeline progress and strong partnerships drive fiscal year 2025
News Preview
Press Release // November 13, 2025
Formycon publishes nine-month results and confirms guidance – Pipeline progress and strong partnerships drive fiscal year 2025
Guidance for 2025 confirmed – Revenue and earnings development in line with expectations
FYB202 (Stelara®1 biosimilar): Market penetration in the US and Europe continues
Significant ......
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ZEAL
LISTED
CPH
Zealand Pharma Announces Financial Results for the First Nine Months of 2025
News Preview
Company announcement – No. 23 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
INSP
LISTED
NYSE
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commissi...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
LIVN
LISTED
NASDAQ
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap and long-range financial plan.
“We are confident in our ability to deliver on the targets we outlined today. LivaNova’s talented team is focused on a revitalized innovation strategy and op...
Themefolio
Profiler
Peergroup
© EQS Newswire
12.11.2025
ILM1
LISTED
XETR
Montega AG: Medios AG | Rating: Kaufen
News Preview
Original-Research: Medios AG - von Montega AG
12.11.2025 / 17:19 CET/CEST
Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss......
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ZEAL
LISTED
CPH
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
News Preview
Press release – No. 16 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ICLR
LISTED
NASDAQ
ICON plc to Present at the Jefferies London Healthcare Conference
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that Mr. Barry Balfe, CEO of ICON plc and Mr. Nigel Clerkin, CFO of ICON plc, will present at the Jefferies London Healthcare Conference on Wednesday, November 19, 2025 at 9:00 am GMT.
Any changes to this event and links to the live webcast (where available)...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
AUTL
LISTED
NASDAQ
Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
News Preview
Autolus announced its operational and financial results for the third quarter ended September 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
LEGN
LISTED
NASDAQ
Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights
News Preview
SOMERSET, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its third quarter 2025 unaudited financial results and key corporate highlights....
Themefolio
Profiler
Peergroup
© EQS Newswire
12.11.2025
EVT
LISTED
XETR
Evotec erhält Meilenstein-Zahlung von Bristol Myers Squibb nach Zulassung eines IND-Antrags in der strategischen Partnerschaft im Bereich Protein Degradation
News Preview
Meilenstein-Zahlung spiegelt kontinuierliche Fortschritte im Rahmen der strategischen Forschungskooperation wider, die sich auf Patientengruppen mit komplexen oder hohen Versorgungsbedürfnissen fokussiert
Genehmigung des IND-Antrags durch die FDA löst Meilenstein-Zahlung in Höhe von 5 Mio. US$ an Evotec aus
Hamburg, 12. November 2025:......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.11.2025
EVT
LISTED
XETR
Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership
News Preview
Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populations
FDA clearance of IND application triggered a US$ 5 m milestone payment to Evotec
Hamburg, Germany, 12 November 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WK......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
12.11.2025
EVT
LISTED
XETR
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
News Preview
Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populationsFDA clearance of IND application triggered a US$ 5 m milestone payment to Evotec HAMBURG, DE / ACCESS Newswire / November 12, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, W...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.11.2025
REC
LISTED
EURONEXT
RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION
News Preview
NEWS RELEASE...
Themefolio
Profiler
Peergroup
© BusinessWire
11.11.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.11.2025
COLO B
LISTED
CPH
Coloplast A/S - Notice of Annual General Meeting 2025
News Preview
Notice of Annual General Meeting 2025...
Themefolio
Profiler
Peergroup
© EQS Newswire
11.11.2025
ILM1
LISTED
XETR
Medios AG achieves strong growth in earnings and profit margin in the first nine months of 2025
News Preview
Press releaseMedios AG achieves strong growth in earnings and profit margin in the first nine months of 2025
Revenue increases by 9.2% to €1,530.0 million
Disproportionately high EBITDA pre1 increase of 26.1%
Organic EBITDA pre1 growth of 5.1%
Cash flow from operating activities almost doubles
Significant improvement in earnings per share to €......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.11.2025
ILM1
LISTED
XETR
Medios AG erzielt kräftiges Wachstum von Ergebnis und Ergebnismarge im Neunmonatszeitraum 2025
News Preview
Pressemitteilung
Medios AG erzielt kräftiges Wachstum von Ergebnis und Ergebnismarge im Neunmonatszeitraum 2025
Umsatzsteigerung um 9,2 % auf 1.530,0 Mio. €
Überproportionaler EBITDA-pre1-Anstieg um 26,1 %
Organisches EBITDA-pre1-Wachstum von 5,1 %,
Cashflow aus betrieblicher Tätigkeit nahezu verdoppelt
Signifikante Verbesserung des Ergebniss......
Themefolio
Profiler
Peergroup
© Newsfile
11.11.2025
COPN
LISTED
SIX
Cosmo's ESG Rating Upgraded by S&P Global; Strengthens Supplier Sustainability Oversight Engagement, and Italian Manufacturing Plant Awarded EcoVadis Bronze Medal
News Preview
Dublin, Ireland--(Newsfile Corp. - November 11, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced two major milestones in its sustainability journey, underscoring its commitment to transparency, responsible operations, and ESG leadership. Cosmo̵...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
